<?xml version="1.0" encoding="UTF-8"?>
<p>The approaches boosting innate antiviral immune response are more interesting for older persons with a weakened immune system, but the risk is to introduce the drugs too late in the infection process. Identifying people at-risk for COVID-19 is necessary to put in place effective and personalized preventive measures. To identify at-risk people, it would be interesting to determine their “immune-age” or “biological age” (
 <xref ref-type="bibr" rid="CR64">64</xref>) rather than relying only on chronological age. It will ensure a personalized therapeutic care, with benefits against SARS-CoV-2 infection.
</p>
